Zhanwang Xu
- Orthopedics and Sports Medicine top 10%
- Rheumatology top 10%
- Osteoarthritis Treatment and Mechanisms 7
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds 3
-
- Bone Metabolism and Diseases 11
- Inflammasome and immune disorders 4
-
- Spine and Intervertebral Disc Pathology 5
- Spinal Cord Injury Research 4
-
- Biomarkers in Disease Mechanisms 4
-
- Spinal Fractures and Fixation Techniques 4
- Journals
- Experimental Cell Research (1 paper)European Journal of Pharmacology (1 paper)Pharmacological Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zhanwang Xu
40 papers receiving 772 citations
Peers
Comparison fields: 5 of 98
- Orthopedics and Sports Medicine 80
- Rheumatology 131
- Cancer Research 116
- Pharmacology 64
- Molecular Biology 429
Countries citing papers authored by Zhanwang Xu
This map shows the geographic impact of Zhanwang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanwang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanwang Xu more than expected).
Fields of papers citing papers by Zhanwang Xu
This network shows the impact of papers produced by Zhanwang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanwang Xu. The network helps show where Zhanwang Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhanwang Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 9 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 115 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 18 | |
| 15 | 2015 | 10 | |
| 16 | 2014 | 18 | |
| 17 | 2013 | 75 | |
| 18 | 2013 | 3 | |
| 19 | 2013 | 31 | |
| 20 | XLINICAL STUDY ON COMPATIBILITY OF RABBIT MARROW STROMA CELLS AND BIOLOGICAL ACTIVITY GLASS FRAME | 2008 | 1 |
About Zhanwang Xu
Zhanwang Xu is a scholar working on Rheumatology, Cancer Research and Orthopedics and Sports Medicine, having authored 44 papers that have together received 780 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (11 papers), Osteoarthritis Treatment and Mechanisms (7 papers), Spine and Intervertebral Disc Pathology (5 papers), Biomarkers in Disease Mechanisms (4 papers), Spinal Fractures and Fixation Techniques (4 papers), Spinal Cord Injury Research (4 papers), Inflammasome and immune disorders (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (80 citations), Rheumatology (131 citations) and Cancer Research (116 citations). Zhanwang Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Nianhu Li, Zhichao Li, Shang‐You Yang, Paul H. Wooley, Dandan Li, Shigui Yan, Weiqi Yan, Kerong Dai, Wenxiang Cheng and Peng Zhang. Their work appears in journals such as Experimental Cell Research, European Journal of Pharmacology and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.